“…These phenotypic changes in lipid metabolism are directly or indirectly coupled to other phenotypes, such as an irregular expansion of the nuclear/ER membrane, marked vacuole fragmentation, and increased fatty acid-induced lipotoxicity (11,29,34,35,38). Similarly, in mammalian cells, loss of lipin PAP activity results in metabolic disorders that include lipodystrophy, insulin resistance, peripheral neuropathy, rhabdomyolysis, and inflammation (30,(93)(94)(95)(96)(97)(98)(99)(100)(101).…”